CYP2C19 is a gene that codes for an enzyme involved in the metabolism of many medications, including Celexa. Genetic variations of the CYP2C19 gene can affect how quickly or slowly medications are metabolized in the body, which can impact their effectiveness and safety. Healthcare providers should assess an individual’s CYP2C19 status and adjust medication dosages accordingly to ensure safe use of the medication.
« Back to Glossary IndexCYP2C19
« Back to Glossary Index